Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • PKhongthon
    Junior Member
    • Apr 2015
    • 2

    The problem with sensitivity analysis of somatic variant caller

    Hello!

    I'm working on somatic variant identification from cancer samples. So, I try to simulate Illumina paired-end read with known variants by using VarSim (http://bioinform.github.io/varsim/), which this tools can simulate the human genome with both germline and somatic mutations (use ART tool as a simulator). In addition, I had simulated tumor reads by vary allele frequency in the range of 0.1 - 0.5.

    As this paper "Detecting somatic point mutations in cancer genome sequencing data: a comparison of mutation callers" (DOI: 10.1186/gm495) mentioned about the sensitivity of any somatic variant caller including MuTect, SomaticSniper, VarScan, Strelka, and JointSNVMix. I had followed the command of any tools that they provide in supplement to calling somatic variations. However, the sensitivity is quite low when compare with their reports. The maximum is around 0.9 at allele frequency equal to 0.5 (MuTect) while at allele frequency equal to 0.5 (MuTect) I got the sensitivity just 0.7 (my simulated reads are chr22).

    So, I have no idea that why the results are very different, even I use only chr22 but I think the results shouldn't be much different.

    Additional, I aligned the reads by using bwa-mem then mark duplicates with Picard-tool and realigned, recalibration with GATK

Latest Articles

Collapse

  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM
  • GATTACAT
    Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
    by GATTACAT
    Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
    07-01-2026, 11:43 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
31 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-08-2026, 10:08 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-07-2026, 11:05 AM
0 responses
34 views
0 reactions
Last Post SEQadmin2  
Working...